SCM
AZN icon

Saxony Capital Management’s AstraZeneca AZN Stock Holding History

Saxony Capital Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$239K Hold
1,275
– – 0.11% 151
2026
Q1 		$247K Sell
1,275
-49
-4% -$9.45K 0.14% 132
2025
Q4 		$243K Hold
1,324
– – 0.15% 127
2025
Q3 		$203K Buy
+1,324
New +$200K 0.13% 149
2024
Q4 		– Sell
-1,324
Closed -$206K – 134
2024
Q3 		$206K Buy
+1,324
New +$214K 0.19% 124

Other funds holding AZN

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
CAM
Cidel Asset Management Toronto, Ontario, Ontario, Canada $2.08B AUM 24.89% 1-Year Est. Return
MBI
Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return
SAM
Sycomore Asset Management Paris, France $932M AUM 51.25% 1-Year Est. Return

Saxony Capital Management's AZN Position: Q2 2026 in Review

Saxony Capital Management held its AstraZeneca (AZN) position steady in Q2 2026 at 1,275 shares worth $239K. The position accounts for 0.11% of the portfolio, ranked #151.

Saxony Capital Management first reported a position in AZN in Q3 2024 and has held it in 5 quarters since. The position peaked at $247K in Q1 2026. 351 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Saxony Capital Management held 1,275 shares of AstraZeneca worth $239K as of Q2 2026.
  • Saxony Capital Management left its AstraZeneca share count unchanged in Q2 2026.
  • AstraZeneca made up 0.11% of Saxony Capital Management's portfolio in Q2 2026, its #151 holding.
  • Saxony Capital Management first reported a position in AstraZeneca in Q3 2024 and has held it in 5 quarters since.
  • Saxony Capital Management's AstraZeneca position peaked at $247K in Q1 2026.
  • 351 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Saxony Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.